Ampersand Health

Ampersand Health collaborates with world-renowned researchers, clinicians, and patient groups to create industry-leading personalized digital therapies that help extend remission periods and support self-management of long-term conditions. Ampersand Health is a venture-backed social impact company. We are developing the first scientifically validated digital therapy for people with long-term inflammatory conditions. Our interventions are regulated by the MHRA, CE-marked, and evaluated by NICE and Orcha, with support from clinicians and patients at King’s, King’s College Hospital, and The Royal London, as well as backing from the government, industry, and major patient groups. Research shows that it helps improve outcomes and quality of life for patients with IBD and RA, while reducing healthcare resource utilization and overall care costs.